PET imaging useful for identifying Alzheimer's Disease stage
In a new study reported in JAMA Neurology, researchers at Washington University in St Louis, Missouri, and the University of Alabama - Birmingham, explored the potential of [18F]-AV-1451 positron emission tomography (PET) imaging to serve as a marker of disease staging in Alzheimer’s disease (AD) and to elucidate interactions between β-amyloid and tauopathy. Read more.